BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 37192691)

  • 1. Evaluation of major depressive disorder using 7 Tesla phase sensitive neuroimaging before and after mindfulness-based cognitive therapy.
    Jakary A; Lupo JM; Mackin S; Yin A; Murray D; Yang T; Mukherjee P; Larson P; Xu D; Eisendrath S; Luks T; Li Y
    J Affect Disord; 2023 Aug; 335():383-391. PubMed ID: 37192691
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Evaluating metabolites in patients with major depressive disorder who received mindfulness-based cognitive therapy and healthy controls using short echo MRSI at 7 Tesla.
    Li Y; Jakary A; Gillung E; Eisendrath S; Nelson SJ; Mukherjee P; Luks T
    MAGMA; 2016 Jun; 29(3):523-33. PubMed ID: 26861048
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Relapse/Recurrence Prevention in Major Depressive Disorder: 26-Month Follow-Up of Mindfulness-Based Cognitive Therapy Versus an Active Control.
    Shallcross AJ; Willroth EC; Fisher A; Dimidjian S; Gross JJ; Visvanathan PD; Mauss IB
    Behav Ther; 2018 Sep; 49(5):836-849. PubMed ID: 30146148
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevention of relapse/recurrence in major depressive disorder with either mindfulness-based cognitive therapy or cognitive therapy.
    Farb N; Anderson A; Ravindran A; Hawley L; Irving J; Mancuso E; Gulamani T; Williams G; Ferguson A; Segal ZV
    J Consult Clin Psychol; 2018 Feb; 86(2):200-204. PubMed ID: 29265831
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Relapse prevention in major depressive disorder: Mindfulness-based cognitive therapy versus an active control condition.
    Shallcross AJ; Gross JJ; Visvanathan PD; Kumar N; Palfrey A; Ford BQ; Dimidjian S; Shirk S; Holm-Denoma J; Goode KM; Cox E; Chaplin W; Mauss IB
    J Consult Clin Psychol; 2015 Oct; 83(5):964-75. PubMed ID: 26371618
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A Randomized Controlled Pilot Study on Mindfulness-Based Cognitive Therapy for Unipolar Depression in Patients With Chronic Pain.
    de Jong M; Peeters F; Gard T; Ashih H; Doorley J; Walker R; Rhoades L; Kulich RJ; Kueppenbender KD; Alpert JE; Hoge EA; Britton WB; Lazar SW; Fava M; Mischoulon D
    J Clin Psychiatry; 2018; 79(1):. PubMed ID: 28252881
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Factors associated with relapse and recurrence of major depressive disorder in patients starting mindfulness-based cognitive therapy.
    de Klerk-Sluis JM; Huijbers MJ; Löcke S; Spijker J; Spinhoven P; Speckens AEM; Ruhe HG
    Depress Anxiety; 2022 Feb; 39(2):113-122. PubMed ID: 34752681
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The effectiveness and cost-effectiveness of mindfulness-based cognitive therapy compared with maintenance antidepressant treatment in the prevention of depressive relapse/recurrence: results of a randomised controlled trial (the PREVENT study).
    Kuyken W; Hayes R; Barrett B; Byng R; Dalgleish T; Kessler D; Lewis G; Watkins E; Morant N; Taylor RS; Byford S
    Health Technol Assess; 2015 Sep; 19(73):1-124. PubMed ID: 26379122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Cost-Utility Analysis of Mindfulness-Based Cognitive Therapy Versus Antidepressant Pharmacotherapy for Prevention of Depressive Relapse in a Canadian Context: Analyse coût-utilité de la thérapie cognitive basée sur la pleine conscience contre la pharmacothérapie antidépressive pour prévenir la rechute de la dépression en contexte canadien.
    Pahlevan T; Ung C; Segal Z
    Can J Psychiatry; 2020 Aug; 65(8):568-576. PubMed ID: 32031000
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effects of Mindfulness-Based Cognitive Therapy on Major Depressive Disorder with Multiple Episodes: A Systematic Review and Meta-Analysis.
    Tseng HW; Chou FH; Chen CH; Chang YP
    Int J Environ Res Public Health; 2023 Jan; 20(2):. PubMed ID: 36674310
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mindfulness-Based Cognitive Therapy for Patients With Depression Decreases the Need for Outpatient Visits.
    Bota RG; Hazen J; Tieu R; Novac A
    Prim Care Companion CNS Disord; 2016 Aug; 18(4):. PubMed ID: 27828695
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Added value of Mindfulness-Based Cognitive Therapy for Depression: A Tree-based Qualitative Interaction Analysis.
    Ter Avest MJ; Dusseldorp E; Huijbers MJ; van Aalderen JR; Cladder-Micus MB; Spinhoven P; Greven CU; Speckens AEM
    Behav Res Ther; 2019 Nov; 122():103467. PubMed ID: 31557693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-Intensity Guided Help Through Mindfulness (LIGHTMIND): study protocol for a randomised controlled trial comparing supported mindfulness-based cognitive therapy self-help to supported cognitive behavioural therapy self-help for adults experiencing depression.
    Strauss C; Arbon A; Barkham M; Byford S; Crane R; de Visser R; Heslin M; Jones AM; Jones F; Lea L; Parry G; Rosten C; Cavanagh K
    Trials; 2020 May; 21(1):374. PubMed ID: 32366320
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cognitive reactivity as outcome and working mechanism of mindfulness-based cognitive therapy for recurrently depressed patients in remission.
    Cladder-Micus MB; van Aalderen J; Donders ART; Spijker J; Vrijsen JN; Speckens AEM
    Cogn Emot; 2018 Mar; 32(2):371-378. PubMed ID: 28278742
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Mindfulness-based cognitive therapy reduces clinical symptoms, but do not change frontal alpha asymmetry in people with major depression disorder.
    Szumska I; Gola M; Rusanowska M; Krajewska M; Żygierewicz J; Krejtz I; Nezlek JB; Holas P
    Int J Neurosci; 2021 May; 131(5):453-461. PubMed ID: 32223344
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Follow-up outcomes of Mindfulness-Based Cognitive Therapy (MBCT) for patients with chronic, treatment-resistant depression.
    Cladder-Micus MB; Vrijsen JN; Fest A; Spijker J; Donders ART; Becker ES; Speckens AEM
    J Affect Disord; 2023 Aug; 335():410-417. PubMed ID: 37178825
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mindfulness-based cognitive therapy for patients with chronic, treatment-resistant depression: A pragmatic randomized controlled trial.
    Cladder-Micus MB; Speckens AEM; Vrijsen JN; T Donders AR; Becker ES; Spijker J
    Depress Anxiety; 2018 Oct; 35(10):914-924. PubMed ID: 30088834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Mindfulness-based cognitive therapy (MBCT) versus the health-enhancement program (HEP) for adults with treatment-resistant depression: a randomized control trial study protocol.
    Eisendrath SJ; Gillung EP; Delucchi KL; Chartier M; Mathalon DH; Sullivan JC; Segal ZV; Feldman MD
    BMC Complement Altern Med; 2014 Mar; 14():95. PubMed ID: 24612825
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A randomised controlled trial to investigate the clinical effectiveness and cost effectiveness of Mindfulness-Based Cognitive Therapy (MBCT) for depressed non-responders to Increasing Access to Psychological Therapies (IAPT) high-intensity therapies: study protocol.
    Barnhofer T; Dunn BD; Strauss C; Ruths F; Barrett B; Ryan M; Ladwa A; Stafford F; Fichera R; Baber H; McGuinness A; Metcalfe I; Harding D; Walker S; Ganguli P; Rhodes S; Young A; Warren F
    Trials; 2023 Jan; 24(1):43. PubMed ID: 36658663
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Impact of Mindfulness-Based Cognitive Therapy on Depressive Symptoms Reduction among Depressed Patients in Nigeria: A Randomized Controlled Trial.
    Musa ZA; Soh KL; Mukhtar F; Soh KY; Oladele TO; Soh KG
    Issues Ment Health Nurs; 2021 Jul; 42(7):667-675. PubMed ID: 32996802
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.